The Relationship of Antipsychotic Medication Class and Adherence with Treatment Outcomes and Costs for Florida Medicaid Beneficiaries with Schizophrenia

被引：0
作者：
Marion A. Becker
M. Scott Young
Ezra Ochshorn
Ronald J. Diamond
机构：
[1] University of South Florida,Department of Mental Health Law & Policy—MHC 2735, Louis de la Parte Florida Mental Health Institute
[2] University of South Florida,Department of Mental Health Law & Policy—MHC 2603, Louis de la Parte Florida Mental Health Institute
[3] University of South Florida,Department of Mental Health Law & Policy—MHC 2625G, Louis de la Parte Florida Mental Health Institute
[4] University of Wisconsin-Madison,Department of Psychiatry
来源：
Administration and Policy in Mental Health and Mental Health Services Research | 2007年 / 34卷
关键词：
Antipsychotic medication; Adherence; Medicaid; Cost-effectiveness;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
While some studies show a significant advantage in adherence rates with use of atypical versus typical antipsychotic medication, others show no advantage or mixed results (Jones et al. (2006). Archives of General Psychiatry, 63, 1079–1087; Rosenheck, (2006). Archives of General Psychiatry, 63, 1074–1076). This study examined treatment outcomes and costs associated with adherence rates by antipsychotic medication class for adult Medicaid beneficiaries in Florida diagnosed with schizophrenia. Outcomes examined include arrests, involuntary commitments, and physical and behavioral healthcare costs. Study findings demonstrate that medication adherence for persons with schizophrenia may be as important to treatment costs and benefits as the class of medication used.
引用
收藏
页码：307 / 314
页数：7
相关论文
共 167 条
[1]  
Andreasen N. C.(2005)Remission in schizophrenia: Proposed criteria and rationale for consensus American Journal of Psychiatry 162 441-449
[2]  
Carpenter W. T.(2004)New antipsychotics, compliance, quality of life, and subjective tolerability—Are patients better off? Canadian Journal of Psychiatry 49 297-302
[3]  
Kane J. M.(1999)Issues in the psychiatric treatment of African Americans Psychiatric Services 50 362-350
[4]  
Lasser R. A.(2003)The bursting State Fiscal Bubble and State Medical Budgets Health Affairs 22 46-61
[5]  
Marder S. R.(1999)Atypical antipsychotics, part II: Adverse effects, drug interactions, and costs Annals of Pharmacotherapy 33 210-217
[6]  
Weinberger D. R.(2002)Relapse and rehospitalisation rates in patients with schizophrenia: Effects of second generation antipsychotics CNS Drugs 16 473-484
[7]  
Awad A. G.(2003)Outpatient prescriptions for atypical antipsychotics for African Americans, Hispanics, and Whites in the United States Archives of General Psychiatry 60 121-128
[8]  
Voruganti L. N.(2003)A meta-analysis of the efficacy of second generation antipsychotics Archive of General Psychiatry 60 553-564
[9]  
Baker F. M.(2002)Antipsychotic medication adherence: Is there a difference between typical and atypical agents? American Journal of Psychiatry 159 103-108
[10]  
Bell C.(2003)Adherence to antipsychotic and nonpsychiatric medications in middle-aged and older patients with psychotic disorders Psychosomatic Medicine 65 156-162
12345678910